# Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin

> **NCT01929798** · EARLY_PHASE1 · COMPLETED · sponsor: **Sansum Diabetes Research Institute** · enrollment: 36 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** portable Artificial Pancreas

## Key facts

- **NCT ID:** NCT01929798
- **Lead sponsor:** Sansum Diabetes Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929798, "Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01929798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*